195 related articles for article (PubMed ID: 33030228)
1. Periodontal surgery using rhFGF-2 with deproteinized bovine bone mineral or rhFGF-2 alone: 2-year follow-up of a randomized controlled trial.
Aoki H; Bizenjima T; Seshima F; Sato M; Irokawa D; Yoshikawa K; Yoshida W; Imamura K; Matsugami D; Kitamura Y; Kita D; Sugito H; Tomita S; Saito A
J Clin Periodontol; 2021 Jan; 48(1):91-99. PubMed ID: 33030228
[TBL] [Abstract][Full Text] [Related]
2. Treatment of intrabony periodontal defects using rhFGF-2 in combination with deproteinized bovine bone mineral or rhFGF-2 alone: A 6-month randomized controlled trial.
Saito A; Bizenjima T; Takeuchi T; Suzuki E; Sato M; Yoshikawa K; Kitamura Y; Matsugami D; Aoki H; Kita D; Imamura K; Irokawa D; Seshima F; Tomita S
J Clin Periodontol; 2019 Mar; 46(3):332-341. PubMed ID: 30758076
[TBL] [Abstract][Full Text] [Related]
3. Periodontal Regenerative Therapy Using rhFGF-2 and Deproteinized Bovine Bone Mineral versus rhFGF-2 Alone: 4-Year Extended Follow-Up of a Randomized Controlled Trial.
Seshima F; Bizenjima T; Aoki H; Imamura K; Kita D; Irokawa D; Matsugami D; Kitamura Y; Yamashita K; Sugito H; Tomita S; Saito A
Biomolecules; 2022 Nov; 12(11):. PubMed ID: 36421696
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Chronic Periodontitis with Recombinant Human Fibroblast Growth Factor-2 and Deproteinized Bovine Bone Mineral in Wide Intrabony Defects:12-month Follow-up Case Series.
Yoshida W; Takeuchi T; Imamura K; Seshima F; Saito A; Tomita S
Bull Tokyo Dent Coll; 2020 Dec; 61(4):231-241. PubMed ID: 33177268
[TBL] [Abstract][Full Text] [Related]
5. Effect of systemic antibiotics on the outcomes of regenerative periodontal surgery in intrabony defects: a randomized, controlled, clinical study.
Pietruska M; Dolińska E; Milewski R; Sculean A
Clin Oral Investig; 2021 May; 25(5):2959-2968. PubMed ID: 33048260
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcomes following regenerative therapy of non-contained intrabony defects using a deproteinized bovine bone mineral combined with either enamel matrix derivative or collagen membrane.
Iorio-Siciliano V; Andreuccetti G; Blasi A; Matarasso M; Sculean A; Salvi GE
J Periodontol; 2014 Oct; 85(10):1342-50. PubMed ID: 24835417
[TBL] [Abstract][Full Text] [Related]
7. The role of rhFGF-2 in periodontal defect bone fill: A systematic review of the literature.
Pouliou MM; Fragkioudakis I; Doufexi AE; Batas L
J Periodontal Res; 2023 Aug; 58(4):733-744. PubMed ID: 37130815
[TBL] [Abstract][Full Text] [Related]
8. Periodontal Regenerative Therapy with Recombinant Human Fibroblast Growth Factor-2 and Deproteinized Bovine Bone Mineral in Patient with Chronic Periodontitis: An 18-month Follow-up Report.
Bizenjima T; Irokawa D; Tanaka K; Saito A; Tomita S
Bull Tokyo Dent Coll; 2021 Jun; 62(2):107-117. PubMed ID: 33994421
[TBL] [Abstract][Full Text] [Related]
9. A Case Report of Periodontal Regenerative Therapy Using Recombinant Human Fibroblast Growth Factor 2 and Deproteinized Bovine Bone Mineral with Non-incised Papillae Surgical Approach (NIPSA) for Angular Bone Defect in Patient with Stage III Grade C Periodontitis.
Bizenjima T; Irokawa D; Yamada S; Saito A; Tomita S
Bull Tokyo Dent Coll; 2023 Dec; 64(4):145-155. PubMed ID: 37967939
[TBL] [Abstract][Full Text] [Related]
10. Guided tissue regeneration combined with a deproteinized bovine bone mineral (Bio-Oss) in the treatment of intrabony periodontal defects: 6-year results from a randomized-controlled clinical trial.
Stavropoulos A; Karring T
J Clin Periodontol; 2010 Feb; 37(2):200-10. PubMed ID: 20653820
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of periodontal minimally invasive surgery with and without regenerative materials for treatment of intrabony defect: a randomized clinical trial.
Liu B; Ouyang X; Kang J; Zhou S; Suo C; Xu L; Liu J; Liu W
Clin Oral Investig; 2022 Feb; 26(2):1613-1623. PubMed ID: 34414521
[TBL] [Abstract][Full Text] [Related]
12. Comparison of periodontal wound healing/regeneration by recombinant human fibroblast growth factor-2 combined with β-tricalcium phosphate, carbonate apatite, or deproteinized bovine bone mineral in a canine one-wall intra-bony defect model.
Shirakata Y; Setoguchi F; Sena K; Nakamura T; Imafuji T; Shinohara Y; Iwata M; Noguchi K
J Clin Periodontol; 2022 Jun; 49(6):599-608. PubMed ID: 35322457
[TBL] [Abstract][Full Text] [Related]
13. Guided tissue regeneration/deproteinized bovine bone mineral or papilla preservation flaps alone for treatment of intrabony defects. II: radiographic predictors and outcomes.
Liñares A; Cortellini P; Lang NP; Suvan J; Tonetti MS;
J Clin Periodontol; 2006 May; 33(5):351-8. PubMed ID: 16634957
[TBL] [Abstract][Full Text] [Related]
14. Effect of platelet-rich plasma on the healing of intrabony defects treated with an anorganic bovine bone mineral: a pilot study.
Döri F; Kovács V; Arweiler NB; Huszár T; Gera I; Nikolidakis D; Sculean A
J Periodontol; 2009 Oct; 80(10):1599-605. PubMed ID: 19792848
[TBL] [Abstract][Full Text] [Related]
15. Amnion membrane as a novel barrier in the treatment of intrabony defects: a controlled clinical trial.
Kiany F; Moloudi F
Int J Oral Maxillofac Implants; 2015; 30(3):639-47. PubMed ID: 26009915
[TBL] [Abstract][Full Text] [Related]
16. Human intrabony defect regeneration with rhFGF-2 and hyaluronic acid - a randomized controlled clinical trial.
de Santana RB; de Santana CM
J Clin Periodontol; 2015 Jul; 42(7):658-65. PubMed ID: 25933201
[TBL] [Abstract][Full Text] [Related]
17. Use of bovine-derived anorganic bone associated with guided tissue regeneration in intrabony defects. Six-month evaluation at re-entry.
Batista EL; Novaes AB; Simonpietri JJ; Batista FC
J Periodontol; 1999 Sep; 70(9):1000-7. PubMed ID: 10505802
[TBL] [Abstract][Full Text] [Related]
18. Combined periodontal regenerative technique in human intrabony defects by collagen membranes and anorganic bovine bone. A controlled clinical study.
Paolantonio M
J Periodontol; 2002 Feb; 73(2):158-66. PubMed ID: 11895280
[TBL] [Abstract][Full Text] [Related]
19. Five-year results of a prospective, randomized, controlled study evaluating treatment of intra-bony defects with a natural bone mineral and GTR.
Sculean A; Schwarz F; Chiantella GC; Donos N; Arweiler NB; Brecx M; Becker J
J Clin Periodontol; 2007 Jan; 34(1):72-7. PubMed ID: 17243997
[TBL] [Abstract][Full Text] [Related]
20. Five-year follow-up of regenerative periodontal therapy with enamel matrix derivative at sites with angular bone defects.
Heden G; Wennström JL
J Periodontol; 2006 Feb; 77(2):295-301. PubMed ID: 16460257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
